Yu Xin, Li Zheng, Wu William K K
Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Oncol Res. 2014;22(5-6):339-48. doi: 10.3727/096504015X14424348426116.
TIP30/CC3 was first identified and characterized as a "candidate" tumor-suppressor gene in 1997. Recently, the TIP30 tumor-suppressor status has been fully established since several studies have described that TIP30 protein expression is frequently downregulated in diverse types of human tumors, and the downregulation is often associated with tumor progression. TIP30 is involved in the control of cell apoptosis, growth, metastasis, angiogenesis, DNA repair, and tumor cell metabolism. Moreover, TIP30(-/-) mice spontaneously develop hepatocellular carcinoma and other tumors at a higher incidence than that of wild-type mice. In this review, we provide an overview of current knowledge concerning the role of TIP30 in tumor development and progression. To our knowledge, this is the first review about the role of novel tumor-suppressor gene TIP30 in tumor development and progression.
TIP30/CC3于1997年首次被鉴定并被描述为一种“候选”肿瘤抑制基因。最近,TIP30的肿瘤抑制状态已被充分确立,因为多项研究表明,TIP30蛋白表达在多种类型的人类肿瘤中经常下调,且这种下调通常与肿瘤进展相关。TIP30参与细胞凋亡、生长、转移、血管生成、DNA修复及肿瘤细胞代谢的调控。此外,TIP30基因敲除小鼠比野生型小鼠更易自发发生肝细胞癌及其他肿瘤。在本综述中,我们概述了目前关于TIP30在肿瘤发生和进展中作用的相关知识。据我们所知,这是关于新型肿瘤抑制基因TIP30在肿瘤发生和进展中作用的首次综述。